Anemia, AplasticMyelodysplastic SyndromesBone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseAnemia, RefractoryAnemiaAnemia, Refractory, with Excess of BlastsTransplantation, AutologousLeukemia, Myeloid, AcuteWhole-Body IrradiationLeukemiaHematopoietic Stem Cell TransplantationTransplantation ConditioningSyndromeBone and BonesAntilymphocyte SerumLeukemia, MyeloidPancytopeniaBone Marrow DiseasesHematopoietic Stem CellsBusulfanTissue DonorsLiver TransplantationTransplantation ChimeraHematopoiesisGraft SurvivalImmunosuppressive AgentsHistocompatibility TestingTreatment OutcomeCyclophosphamideLeukemia, Myelomonocytic, ChronicHistocompatibilityBone Marrow ExaminationAcute DiseaseBone Marrow PurgingRecurrenceRemission InductionTransplantation, IsogeneicCombined Modality TherapyHematologic NeoplasmsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival AnalysisCyclosporineAnemia, SideroblasticFanconi AnemiaImmunosuppressionTime FactorsHematologic DiseasesHemoglobinuria, ParoxysmalKidney TransplantationPrognosisRetrospective StudiesColony-Forming Units AssayGraft vs Host ReactionChromosomes, Human, Pair 5Mice, Inbred C57BLPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft RejectionKaryotypingGranulocyte Colony-Stimulating FactorBlood TransfusionHLA AntigensSurvival RateRadiation ChimeraStem Cell TransplantationBlood Cell CountChromosome AberrationsBone Marrow NeoplasmsMonosomyLymphoma, Non-HodgkinCytarabineMyeloproliferative DisordersLeukocyte CountFollow-Up StudiesAzacitidineT-LymphocytesAntigens, CD34Hepatic Veno-Occlusive DiseaseBone RemodelingAntineoplastic Combined Chemotherapy ProtocolsGranulocytesFatal OutcomeFlow CytometryTransplantation ImmunologyPreleukemiaDisease-Free SurvivalLymphocyte DepletionLeukocyte TransfusionHeart TransplantationThalidomideCytogeneticsSevere Combined ImmunodeficiencyCell DifferentiationErythropoietinChimeraAnemia, MacrocyticErythrocyte Transfusion